These two agree on the most important thing in tirzepatide pricing and disagree on almost everything else.
Both charge one price across the whole dose ladder. Precision Telemed is explicit about why, stating that most providers charge more as the dose increases and calling that a penalty for success. CoreAge Rx says the same thing differently: all doses cost the same, and the price locked at checkout stays fixed for all future months.
The difference is $100 a month. At 12.5 mg, CoreAge Rx is $129 and Precision Telemed is $249.99 — and both are dramatically cheaper than Coby Health's $439 at the same dose, which is what dose-based pricing produces.
What $100 a month buys
Verifiability. Precision Telemed names Rush Pharmacy as its 503A licensed compounder, states it works exclusively with licensed 503A pharmacies and never research-grade suppliers, and publishes eleven clinicians individually — training, specialty and NPI number — starting with medical director Dr Joseph Palumbo, DO. NPI numbers are checkable in the national registry, which no other provider in this market invites you to do.
CoreAge Rx names the physicians assigned in California, Massachusetts, Rhode Island and Vermont with licence numbers, which is more than most. Its pharmacy, though, is not published at all — the FAQ tells you to phone or email support to find out who compounds your medication.
Read Precision Telemed's outcome data carefully
It advertises −15% average body weight, and discloses in its own footnote that this is clinical data from its own practice, not gathered in a controlled setting, among patients who stayed on the protocol six months or more. Selecting on completion inflates any result. The disclosure is honest; the headline is not what it appears.
Also note the scope: Precision Telemed offers tirzepatide only. If you want semaglutide, or think you might switch, CoreAge Rx carries both.
Where a dose sits on the studied ladder
Move the slider to see whether a dose is one the weight-loss trials actually used. Doses below the studied range may still suit you — they simply have no trial result attached.
Standard titration step
Standard schedule: Weeks 1–4
The standard starting dose. Intended to build tolerance, not to produce weight loss.
In the trial programme behind Wegovy, adults reached a 2.4 mg weekly maintenance dose and lost an average of about 15% of body weight over 68 weeks.
Titration schedules are the standard ones for the approved products and are shown for orientation, not as a dosing instruction. Compounded products are not FDA-approved and your prescriber sets your schedule. Never change a dose on the basis of a web page.